STLN
The Oncology Institute, Inc.
Price Chart
Latest Quote
$6.59
+0.30 (+4.77%)
Current Price
| Previous Close | $6.29 |
| Open | $6.28 |
| Day High | $6.62 |
| Day Low | $6.26 |
| Volume | 1,314,775 |
Stock Information
| Shares Outstanding | 101.92M |
| Total Debt | $104.79M |
| Cash Equivalents | $41.09M |
| Revenue | $587.24M |
| Net Income | $-30.56M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $671.63M |
| EPS (TTM) | $-0.29 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $735.33M |
| Sales | $587.24M |
| Income | $-30.56M |
| Book/sh | $-0.25 |
| Cash/sh | $0.40 |
| Employees | 641 |
Financial Ratios
| Quick Ratio | 1.14 |
| Current Ratio | 1.36 |
Returns & Margins
| ROA | -9.65% |
| Gross Margin | 15.69% |
| Operating Margin | -2.86% |
| Profit Margin | -6.18% |
Ownership
| Insider Ownership | 17.83% |
| Institutional Ownership | 46.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1.14 |
| P/B | -26.57 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $9.40 |
Technical Indicators
| SMA20 | $6.54 |
| SMA50 | $6.47 |
| SMA200 | $4.65 |
| RSI | 52.17 |
| ATR | 0.4082 |
| Shares Float | 88.89M |
| Short Float | 7.58% |
| Short Ratio | 5.23 |
| Volatility | 0.42 |
| Rel Volume | 1.08 |
Performance History
| Week | -0.60% |
| Month | -0.75% |
| Quarter | +38.16% |
| 6 Months | +91.57% |
| YTD | +79.56% |
| Year | +38.74% |
| 3 Years | +325.16% |
| 5 Years | -33.84% |
| 10 Years | -32.06% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $6.59 | 1,314,800 |
| 2026-10-26 | $6.29 | 1,862,500 |
| 2026-10-23 | $6.71 | 1,055,900 |
| 2026-10-22 | $6.91 | 870,100 |
| 2026-10-21 | $6.83 | 1,454,000 |
| 2026-10-20 | $6.63 | 1,097,400 |
| 2026-10-19 | $6.46 | 983,000 |
| 2026-10-16 | $6.43 | 1,773,500 |
| 2026-10-15 | $6.91 | 1,186,800 |
| 2026-10-14 | $6.51 | 1,338,300 |
| 2026-10-13 | $6.70 | 1,277,500 |
| 2026-10-12 | $6.92 | 965,000 |
| 2026-10-09 | $6.63 | 1,848,300 |
| 2026-10-08 | $6.18 | 1,251,000 |
| 2026-10-07 | $6.43 | 949,100 |
| 2026-10-06 | $6.58 | 985,800 |
| 2026-10-05 | $6.30 | 1,336,800 |
| 2026-10-02 | $6.35 | 793,900 |
| 2026-10-01 | $6.22 | 994,200 |
| 2026-09-30 | $6.32 | 946,900 |
| 2026-09-29 | $6.51 | 972,900 |
| 2026-09-28 | $6.64 | 919,200 |
About The Oncology Institute, Inc.
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on STLN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $426,294,000 | $339,415,000 | $264,666,000 | $200,390,000 |
| Cost Of Revenue | $426,294,000 | $339,415,000 | $264,666,000 | $200,390,000 |
| Total Revenue | $502,729,000 | $393,412,000 | $324,239,000 | $252,483,000 |
| Operating Revenue | $502,729,000 | $393,412,000 | $324,239,000 | $252,483,000 |
| Expenses | ||||
| Interest Expense | $11,276,000 | $7,496,000 | $6,777,000 | $4,082,000 |
| Total Expenses | $538,812,000 | $453,530,000 | $384,390,000 | $324,490,000 |
| Other Income Expense | $-13,378,000 | $2,951,000 | $-16,176,000 | $75,998,000 |
| Other Non Operating Income Expenses | $-925,000 | $-365,000 | $-704,000 | $501,000 |
| Net Non Operating Interest Income Expense | $-11,276,000 | $-7,496,000 | $-6,777,000 | $-4,082,000 |
| Interest Expense Non Operating | $11,276,000 | $7,496,000 | $6,777,000 | $4,082,000 |
| Operating Expense | $112,518,000 | $114,115,000 | $119,724,000 | $124,100,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Net Interest Income | $-11,276,000 | $-7,496,000 | $-6,777,000 | $-4,082,000 |
| Normalized Income | $-48,179,151 | $-67,979,000 | $-67,602,702 | $-59,490,630 |
| Net Income From Continuing And Discontinued Operation | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Total Operating Income As Reported | $-36,083,000 | $-60,118,000 | $-77,018,000 | $-81,951,000 |
| Net Income Common Stockholders | $-50,305,000 | $-53,005,000 | $-67,877,000 | $68,000 |
| Net Income | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Net Income Including Noncontrolling Interests | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Net Income Continuous Operations | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Pretax Income | $-60,737,000 | $-64,663,000 | $-83,104,000 | $-91,000 |
| Operating Income | $-36,083,000 | $-60,118,000 | $-60,151,000 | $-72,007,000 |
| Depreciation Amortization Depletion Income Statement | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Depreciation And Amortization In Income Statement | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Gross Profit | $76,435,000 | $53,997,000 | $59,573,000 | $52,093,000 |
| Special Income Charges | - | $0 | $-16,064,000 | $49,454,000 |
| Average Dilution Earnings | - | - | $0 | $-17,048,000 |
| Per Share | ||||
| Diluted EPS | $-0.54 | $-0.71 | $-0.92 | $-0.20 |
| Basic EPS | $-0.54 | $-0.71 | $-0.92 | $0.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $-26,151 | $0 | $-6,702 | $15,854,370 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-30,064,000 | $-54,196,000 | $-54,982,000 | $-67,095,000 |
| Total Unusual Items | $-12,453,000 | $3,316,000 | $-15,472,000 | $75,497,000 |
| Total Unusual Items Excluding Goodwill | $-12,453,000 | $3,316,000 | $-15,472,000 | $75,497,000 |
| Reconciled Depreciation | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| EBITDA (Bullshit earnings) | $-42,517,000 | $-50,880,000 | $-70,454,000 | $8,402,000 |
| EBIT | $-49,461,000 | $-57,167,000 | $-76,327,000 | $3,991,000 |
| Diluted Average Shares | $92,389,381 | $75,043,678 | $73,748,660 | $80,605,600 |
| Basic Average Shares | $92,389,381 | $75,043,678 | $73,748,660 | $72,793,497 |
| Diluted NI Availto Com Stockholders | $-50,305,000 | $-53,005,000 | $-67,877,000 | $-16,980,000 |
| Otherunder Preferred Stock Dividend | $-10,301,000 | $-11,658,000 | $-15,191,000 | $84,000 |
| Tax Provision | $-131,000 | $0 | $-36,000 | $-243,000 |
| Gain On Sale Of Security | $-12,453,000 | $3,316,000 | $592,000 | $26,043,000 |
| Selling General And Administration | $105,574,000 | $107,828,000 | $113,851,000 | $119,689,000 |
| Impairment Of Capital Assets | - | $0 | $16,867,000 | $9,944,000 |
| Restructuring And Mergern Acquisition | - | $0 | $-803,000 | $-59,215,000 |
| Other Special Charges | - | - | - | $-183,000 |
Fetched: 2026-10-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-33,965,000 | $-18,451,000 | $31,891,000 | $83,800,000 |
| Total Assets | $164,656,000 | $172,717,000 | $209,240,000 | $261,665,000 |
| Total Non Current Assets | $51,909,000 | $60,299,000 | $65,747,000 | $131,247,000 |
| Other Non Current Assets | $606,000 | $589,000 | $561,000 | $477,000 |
| Goodwill And Other Intangible Assets | $18,245,000 | $22,040,000 | $25,134,000 | $39,375,000 |
| Other Intangible Assets | $11,015,000 | $14,810,000 | $17,904,000 | $17,957,000 |
| Current Assets | $112,747,000 | $112,418,000 | $143,493,000 | $130,418,000 |
| Other Current Assets | $2,987,000 | $4,029,000 | $4,049,000 | - |
| Inventory | $16,875,000 | $10,039,000 | $13,678,000 | $9,261,000 |
| Receivables | $59,320,000 | $48,681,000 | $42,911,000 | $40,433,000 |
| Other Receivables | $322,000 | $346,000 | $551,000 | $343,000 |
| Accounts Receivable | $58,998,000 | $48,335,000 | $42,360,000 | $39,816,000 |
| Cash Cash Equivalents And Short Term Investments | $33,565,000 | $49,669,000 | $82,855,000 | $73,806,000 |
| Cash And Cash Equivalents | $33,565,000 | $49,669,000 | $33,488,000 | $14,010,000 |
| Investmentin Financial Assets | - | - | $0 | $58,354,000 |
| Prepaid Assets | - | - | $4,049,000 | $6,918,000 |
| Accrued Interest Receivable | - | - | $242,000 | $274,000 |
| Restricted Cash | - | - | - | $0 |
| Cash Financial | - | - | - | $14,010,000 |
| Debt | ||||
| Net Debt | $43,835,000 | $43,462,000 | $53,338,000 | $66,611,000 |
| Total Debt | $103,687,000 | $123,152,000 | $119,675,000 | $108,179,000 |
| Long Term Debt And Capital Lease Obligation | $96,531,000 | $116,354,000 | $113,312,000 | $102,681,000 |
| Long Term Debt | $77,400,000 | $93,131,000 | $86,826,000 | $80,621,000 |
| Current Debt And Capital Lease Obligation | $7,156,000 | $6,798,000 | $6,363,000 | $5,498,000 |
| Current Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $180,376,000 | $169,128,000 | $152,215,000 | $138,490,000 |
| Total Non Current Liabilities Net Minority Interest | $109,414,000 | $116,913,000 | $117,427,000 | $108,770,000 |
| Other Non Current Liabilities | $28,000 | $125,000 | $365,000 | $868,000 |
| Derivative Product Liabilities | $12,855,000 | $402,000 | $3,718,000 | $5,113,000 |
| Non Current Deferred Liabilities | $0 | $32,000 | $32,000 | $108,000 |
| Non Current Deferred Taxes Liabilities | $0 | $32,000 | $32,000 | $108,000 |
| Current Liabilities | $70,962,000 | $52,215,000 | $34,788,000 | $29,720,000 |
| Other Current Liabilities | $4,305,000 | $5,310,000 | $3,601,000 | $3,234,000 |
| Current Deferred Liabilities | $4,037,000 | $5,729,000 | $3,296,000 | $1,941,000 |
| Payables And Accrued Expenses | $48,371,000 | $27,403,000 | $19,611,000 | $13,737,000 |
| Interest Payable | $878,000 | $1,136,000 | $1,124,000 | $1,100,000 |
| Payables | $43,167,000 | $24,324,000 | $14,429,000 | $9,627,000 |
| Accounts Payable | $43,167,000 | $24,324,000 | $14,429,000 | $9,372,000 |
| Total Tax Payable | - | - | $0 | $255,000 |
| Income Tax Payable | - | - | $0 | $255,000 |
| Equity | ||||
| Common Stock Equity | $-15,720,000 | $3,589,000 | $57,025,000 | $123,175,000 |
| Total Equity Gross Minority Interest | $-15,720,000 | $3,589,000 | $57,025,000 | $123,175,000 |
| Stockholders Equity | $-15,720,000 | $3,589,000 | $57,025,000 | $123,175,000 |
| Retained Earnings | $-271,419,000 | $-210,813,000 | $-146,150,000 | $-63,082,000 |
| Other | ||||
| Treasury Shares Number | $1,733,774 | $1,733,774 | $1,733,774 | - |
| Ordinary Shares Number | $98,863,144 | $75,737,112 | $74,145,251 | $73,265,621 |
| Share Issued | $100,596,918 | $77,470,886 | $75,879,025 | $73,265,621 |
| Tangible Book Value | $-33,965,000 | $-18,451,000 | $31,891,000 | $83,800,000 |
| Invested Capital | $61,680,000 | $96,720,000 | $143,851,000 | $203,796,000 |
| Working Capital | $41,785,000 | $60,203,000 | $108,705,000 | $100,698,000 |
| Capital Lease Obligations | $26,287,000 | $30,021,000 | $32,849,000 | $27,558,000 |
| Total Capitalization | $61,680,000 | $96,720,000 | $143,851,000 | $203,796,000 |
| Treasury Stock | $1,019,000 | $1,019,000 | $1,019,000 | $0 |
| Additional Paid In Capital | $256,708,000 | $215,413,000 | $204,186,000 | $186,250,000 |
| Capital Stock | $10,000 | $8,000 | $8,000 | $7,000 |
| Common Stock | $10,000 | $8,000 | $8,000 | $7,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $19,131,000 | $23,223,000 | $26,486,000 | $22,060,000 |
| Current Deferred Revenue | $2,282,000 | $2,351,000 | $1,090,000 | $1,139,000 |
| Current Capital Lease Obligation | $7,156,000 | $6,798,000 | $6,363,000 | $5,498,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $7,093,000 | $6,975,000 | $5,518,000 | $5,310,000 |
| Current Accrued Expenses | $5,204,000 | $3,079,000 | $5,182,000 | $4,110,000 |
| Goodwill | $7,230,000 | $7,230,000 | $7,230,000 | $21,418,000 |
| Net PPE | $33,058,000 | $37,670,000 | $40,052,000 | $33,041,000 |
| Accumulated Depreciation | $-10,926,000 | $-6,972,000 | $-6,180,000 | $-3,506,000 |
| Gross PPE | $43,984,000 | $44,642,000 | $46,232,000 | $36,547,000 |
| Leases | $12,849,000 | $12,502,000 | $9,214,000 | $6,655,000 |
| Construction In Progress | $1,137,000 | $106,000 | $1,801,000 | $1,144,000 |
| Other Properties | $24,080,000 | $27,434,000 | $31,458,000 | $26,003,000 |
| Machinery Furniture Equipment | $5,918,000 | $4,600,000 | $3,759,000 | $2,745,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $16,875,000 | $10,039,000 | $13,678,000 | $9,261,000 |
| Other Short Term Investments | - | $0 | $49,367,000 | $59,796,000 |
| Investments And Advances | - | - | $0 | $58,354,000 |
| Available For Sale Securities | - | - | - | $58,354,000 |
| Line Of Credit | - | - | - | - |
Fetched: 2026-10-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-27,787,000 | $-30,327,000 | $-40,882,000 | $-67,285,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-24,587,000 | $-26,538,000 | $-36,315,000 | $-61,756,000 |
| Cash Flow From Continuing Operating Activities | $-24,587,000 | $-26,538,000 | $-36,315,000 | $-61,756,000 |
| Operating Gains Losses | $14,851,000 | $-3,045,000 | $-622,000 | $-26,205,000 |
| Investing Activities | ||||
| Capital Expenditure | $-3,200,000 | $-3,789,000 | $-4,567,000 | $-5,529,000 |
| Investing Cash Flow | $-3,074,000 | $46,211,000 | $62,640,000 | $-131,614,000 |
| Cash Flow From Continuing Investing Activities | $-3,074,000 | $46,211,000 | $62,640,000 | $-131,614,000 |
| Net Other Investing Changes | $126,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $29,200,000 | $0 | - | $0 |
| Financing Cash Flow | $11,557,000 | $-3,492,000 | $-6,847,000 | $92,206,000 |
| Cash Flow From Continuing Financing Activities | $11,557,000 | $-3,492,000 | $-6,847,000 | $92,206,000 |
| Net Other Financing Charges | $-1,041,000 | $-3,528,000 | $-5,853,000 | $-9,594,000 |
| Net Common Stock Issuance | $29,200,000 | $0 | $-1,019,000 | $-9,000,000 |
| Common Stock Issuance | $29,200,000 | $0 | - | - |
| Repurchase Of Capital Stock | - | $0 | $-1,019,000 | $-9,000,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-20,037,000 | $-39,000 | $-101,000 | $-58,000 |
| Interest Paid Supplemental Data | $3,914,000 | $4,498,000 | $4,506,000 | $224,000 |
| End Cash Position | $33,565,000 | $49,669,000 | $33,488,000 | $14,010,000 |
| Beginning Cash Position | $49,669,000 | $33,488,000 | $14,010,000 | $115,174,000 |
| Changes In Cash | $-16,104,000 | $16,181,000 | $19,478,000 | $-101,164,000 |
| Proceeds From Stock Option Exercised | $3,435,000 | $75,000 | $126,000 | $858,000 |
| Net Issuance Payments Of Debt | $-20,037,000 | $-39,000 | $-101,000 | $109,942,000 |
| Net Long Term Debt Issuance | $-20,037,000 | $-39,000 | $-101,000 | $109,942,000 |
| Long Term Debt Payments | $-20,037,000 | $-39,000 | $-101,000 | $-58,000 |
| Net Investment Purchase And Sale | $0 | $50,000,000 | $71,663,000 | $-117,508,000 |
| Sale Of Investment | $0 | $50,000,000 | $81,258,000 | $0 |
| Net PPE Purchase And Sale | $-3,200,000 | $-3,789,000 | $-4,567,000 | $-5,529,000 |
| Purchase Of PPE | $-3,200,000 | $-3,789,000 | $-4,567,000 | $-5,529,000 |
| Change In Working Capital | $1,325,000 | $18,059,000 | $2,359,000 | $-20,541,000 |
| Change In Other Working Capital | $-452,000 | $559,000 | - | - |
| Change In Other Current Liabilities | $-11,000 | $-203,000 | $-5,767,000 | $-4,958,000 |
| Change In Other Current Assets | $-17,000 | $-28,000 | $5,722,000 | $5,247,000 |
| Change In Payables And Accrued Expense | $19,190,000 | $18,686,000 | $8,159,000 | $-3,715,000 |
| Change In Accrued Expense | $-448,000 | $9,471,000 | $3,357,000 | $2,349,000 |
| Change In Payable | $19,638,000 | $9,215,000 | $4,802,000 | $-6,064,000 |
| Change In Account Payable | $19,638,000 | $9,215,000 | $5,057,000 | $-6,187,000 |
| Change In Prepaid Assets | $2,033,000 | $1,176,000 | $3,128,000 | $4,282,000 |
| Change In Inventory | $-6,836,000 | $3,639,000 | $-4,385,000 | $-1,732,000 |
| Change In Receivables | $-12,582,000 | $-5,770,000 | $-4,498,000 | $-19,665,000 |
| Changes In Account Receivables | $-12,308,000 | $-5,975,000 | $-4,564,000 | $-20,285,000 |
| Other Non Cash Items | $8,380,000 | $6,305,000 | $5,402,000 | $-56,771,000 |
| Stock Based Compensation | $4,551,000 | $11,152,000 | $17,810,000 | $27,683,000 |
| Unrealized Gain Loss On Investment Securities | $0 | $-133,000 | $-249,000 | $378,000 |
| Amortization Of Securities | $0 | $-500,000 | $-2,631,000 | $-1,020,000 |
| Deferred Tax | $-32,000 | $0 | $-76,000 | $-263,000 |
| Deferred Income Tax | $-32,000 | $0 | $-76,000 | $-263,000 |
| Depreciation Amortization Depletion | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Depreciation And Amortization | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Gain Loss On Investment Securities | $14,851,000 | $-3,316,000 | $-592,000 | $-26,043,000 |
| Gain Loss On Sale Of PPE | $0 | $271,000 | $-30,000 | $21,000 |
| Net Income From Continuing Operations | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Income Tax Paid Supplemental Data | - | $0 | $403,000 | $150,000 |
| Common Stock Payments | - | $0 | $-1,019,000 | $-9,000,000 |
| Purchase Of Investment | - | $0 | $-9,595,000 | $-117,508,000 |
| Net Business Purchase And Sale | - | $0 | $-4,456,000 | $-8,577,000 |
| Purchase Of Business | - | $0 | $-4,456,000 | $-8,577,000 |
| Change In Tax Payable | - | $0 | $-255,000 | $123,000 |
| Change In Income Tax Payable | - | $0 | $-255,000 | $123,000 |
| Asset Impairment Charge | - | $0 | $18,887,000 | $10,420,000 |
| Issuance Of Debt | - | - | $0 | $110,000,000 |
| Long Term Debt Issuance | - | - | $0 | $110,000,000 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
Fetched: 2026-10-25